UBS AM
OGN icon

UBS AM’s Organon & Co OGN Stock Holding History

UBS AM’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10M Sell
742,009
-36,896
-5% -$441K ﹤0.01% 1241
2026
Q1 		$4.67M Sell
778,905
-24,724
-3% -$186K ﹤0.01% 1586
2025
Q4 		$5.76M Buy
803,629
+6,595
+0.8% +$52.1K ﹤0.01% 1387
2025
Q3 		$8.51M Sell
797,034
-396,895
-33% -$3.9M ﹤0.01% 1128
2025
Q2 		$11.6M Buy
1,193,929
+150,938
+14% +$1.56M ﹤0.01% 1290
2025
Q1 		$15.5M Buy
1,042,991
+26,640
+3% +$410K ﹤0.01% 1064
2024
Q4 		$15.2M Buy
1,016,351
+179,962
+22% +$2.93M ﹤0.01% 1065
2024
Q3 		$16M Buy
836,389
+4,029
+0.5% +$83.5K ﹤0.01% 1032
2024
Q2 		$17.2M Buy
832,360
+372,789
+81% +$7.41M ﹤0.01% 920
2024
Q1 		$8.64M Sell
459,571
-7,640
-2% -$131K ﹤0.01% 1053
2023
Q4 		$6.74M Sell
467,211
-51,053
-10% -$694K ﹤0.01% 1134
2023
Q3 		$9M Sell
518,264
-138,504
-21% -$2.89M ﹤0.01% 991
2023
Q2 		$15.4M Hold
656,768
– – 0.01% 826
2023
Q1 		$15.4M Buy
656,768
+12,983
+2% +$349K 0.01% 826
2022
Q4 		$18M Buy
643,785
+20,910
+3% +$535K 0.01% 783
2022
Q3 		$14.6M Sell
622,875
-67,692
-10% -$2.04M 0.01% 846
2022
Q2 		$23.3M Buy
690,567
+42,485
+7% +$1.49M 0.01% 700
2022
Q1 		$22.6M Buy
648,082
+25,432
+4% +$870K 0.01% 818
2021
Q4 		$19M Buy
622,650
+28,210
+5% +$919K 0.01% 909
2021
Q3 		$19.5M Buy
594,440
+15,262
+3% +$488K 0.01% 876
2021
Q2 		$17.5M Buy
+579,178
New +$19.1M 0.01% 923

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

UBS AM's OGN Position: Q2 2026 in Review

UBS AM reduced its Organon & Co (OGN) stake by 4.7% in Q2 2026, selling an estimated $441K and leaving 742,009 shares worth $10M. The position accounts for ﹤0.01% of the portfolio, ranked #1241.

UBS AM first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $23.3M in Q2 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • UBS AM held 742,009 shares of Organon & Co worth $10M as of Q2 2026.
  • UBS AM sold 36,896 Organon & Co shares in Q2 2026, an estimated $441K.
  • Organon & Co made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1241 holding.
  • UBS AM first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • UBS AM's Organon & Co position peaked at $23.3M in Q2 2022.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.